METHODS, NUCLEIC ACID CONSTRUCTS AND CELLS FOR TREATING NEURODEGENERATIVE DISORDERS

Details for Australian Patent Application No. 2003302134 (hide)

Owner RAMOT AT TEL AVIV UNIVERSITY LTD.

Inventors LEVY, Yosef; OFFEN, Daniel; MELAMED, Eldad

Pub. Number AU-A-2003302134

PCT Number PCT/IL2003/0009

PCT Pub. Number WO2004/046348

Priority 152905 17.11.02 IL

Filing date 17 November 2003

Wipo publication date 15 June 2004

International Classifications

C12N 005/02 Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology

C12N 015/85 Mutation or genetic engineering - for animal cells

A61K 035/28 Medicinal preparations containing material or reaction products thereof with undetermined constitution - Marrow

A61K 049/00 Preparations for testing

A61P 025/16 Drugs for disorders of the nervous system

A61P 025/28 Drugs for disorders of the nervous system

A61P 043/00 Drugs for specific purposes, not provided for in groups

C12N 005/06 Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 005/08 Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

8 July 2004 Complete Application Filed

  Priority application(s): 152905 17.11.02 IL

15 July 2004 Application Open to Public Inspection

  Published as AU-A-2003302134

22 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003302135-Exon 1beta of PDGF receptor alpha gene and utilization thereof

2003302133-NEW USES OF PROTEINS ENCODED BY BLE GENES AND ANTIBIOTICS FROM THE BLEOMYCIN FAMILY